{{Rsnum
|rsid=12657996
|Chromosome=5
|position=159477305
|Orientation=plus
|GMAF=0.2975
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 7.1 | 37.5 | 55.4
| HCB | 10.2 | 40.1 | 49.6
| JPT | 8.9 | 48.2 | 42.9
| YRI | 19.0 | 48.3 | 32.7
| ASW | 16.1 | 44.6 | 39.3
| CHB | 10.2 | 40.1 | 49.6
| CHD | 11.9 | 45.9 | 42.2
| GIH | 7.1 | 45.5 | 47.5
| LWK | 20.0 | 50.9 | 29.1
| MEX | 0.0 | 31.0 | 69.0
| MKK | 27.1 | 52.3 | 20.6
| TSI | 4.9 | 33.3 | 61.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (placlitaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=9E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}